Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits

被引:83
作者
Wei, W
Li, CL
Wang, YY
Su, HD
Zhu, HS
Kritchevsky, D
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[2] Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Biochem Pharmacol, Beijing 100083, Peoples R China
[3] Pharmanex Pharmacol & Clin Ctr, Beijing 100088, Peoples R China
[4] Pharmanex LLC, Provo, UT 84601 USA
关键词
atherosclerosis; Cholestin (Monascus purpureus rice; red yeast rice); HMG-CoA reductase inhibitors; hyperlipidemia; red yeast rice;
D O I
10.1016/S0955-2863(03)00051-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Long-term effects of Cholestin (Monascus purpureus rice; red yeast rice) on serum lipids and severity of atherosclerosis were examined in rabbits fed for 200 days on a semi-purified diet containing 0.25% cholesterol. Serum total cholesterol was 25 and 40% lower, respectively, in rabbits fed 0.4 or 1.35 g/kg/day of Cholestin (Monascus purpureus rice; red yeast rice) compared to controls. This treatment also lowered serum LDL cholesterol. This 200-day treatment significantly reduced serum triglycerides and atherosclerotic index (ratio of non-HDL-cholesterol to HDL-cholesterol). Although similar reductions of total, LDL-cholesterol and triglycerides were observed, a parallel group of rabbits fed lovastatin (0.0024g/kg/day) failed to reduce the index significantly. Apolipoprotein A, was increased and apolipoprotein B was reduced in all treatment groups. Severity of atherosclerosis was reduced significantly in all treatment groups. The sudanophilic area of involvement was 80.6% in controls, and reduced significantly; to 30.1% on the low dose of Cholestin (Monascus purpureus rice; red yeast rice), and 17.2% on the high dose. Lovastatin reduced severity of lesions by 89% (sudanophilia) and 84% (visual). Visual grading of lesion severity showed reduction by 38% and 68%. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:314 / 318
页数:5
相关论文
共 27 条
[1]
DIHYDROMEVINOLIN, A POTENT HYPOCHOLESTEROLEMIC METABOLITE PRODUCED BY ASPERGILLUS-TERREUS [J].
ALBERSSCHONBERG, G ;
JOSHUA, H ;
LOPEZ, MB ;
HENSENS, OD ;
SPRINGER, JP ;
CHEN, J ;
OSTROVE, S ;
HOFFMAN, CH ;
ALBERTS, AW ;
PATCHETT, AA .
JOURNAL OF ANTIBIOTICS, 1981, 34 (05) :507-512
[2]
MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[3]
LOVASTATIN AND SIMVASTATIN - INHIBITORS OF HMG COA REDUCTASE AND CHOLESTEROL-BIOSYNTHESIS [J].
ALBERTS, AW .
CARDIOLOGY, 1990, 77 :14-21
[4]
THIOBARBITURIC ACID TEST FOR DETECTING LIPID PEROXIDES [J].
ASAKAWA, T ;
MATSUSHITA, S .
LIPIDS, 1979, 14 (04) :401-406
[6]
MONACOLIN-J AND MONACOLIN-L NEW INHIBITORS OF CHOLESTEROL-BIOSYNTHESIS PRODUCED BY MONASCUS-RUBER [J].
ENDO, A ;
HASUMI, K ;
NEGISHI, S .
JOURNAL OF ANTIBIOTICS, 1985, 38 (03) :420-422
[8]
MONACOLIN-K, A NEW HYPOCHOLESTEROLEMIC AGENT PRODUCED BY A MONASCUS SPECIES [J].
ENDO, A .
JOURNAL OF ANTIBIOTICS, 1979, 32 (08) :852-854
[10]
Gaw A, 1996, ATHEROSCLEROSIS, V125, P267